GBA Presents: THE GREEN MARKET

Discussion in 'Stocks' started by stonedinvestor, Sep 13, 2021.

  1. THE BEYOND CHALLENGE.


    Beyond Air, Inc. (XAIR)
    6.49+0.03(+0.46%)

    VS

    Beyond Meat, Inc. (BYND)

    56.50-0.04(-0.07%)

    CEO and Chairman of the Board of Beyond Air Inc (30-Year Financial,Insider Trades)Steven A. Lisi(insider trades) bought 40,000 shares of XAIR on 12/10/2021 at an average price of $8.53 a share. The total cost of this purchase was $341,200.
     
    #4711     Jan 30, 2022
    unconventional wisdom likes this.
  2. [​IMG]


    900 STEWART AVENUE, SUITE 301

    GARDEN CITY, NY 11530

    NOTICE OF ANNUAL MEETING OF STOCKHOLDERS

    To Be Held at 4:30 p.m. Eastern Time on Thursday, March 3, 2022


    Dear Stockholders of Beyond Air, Inc.:


    We cordially invite you to attend the 2022 annual meeting of stockholders, which we refer to as the Annual Meeting, of Beyond Air, Inc., a Delaware corporation, which will be held on Thursday, March 3, 2022 at 4:30 p.m. Eastern Time, in person at the offices of Beyond Air, Inc., 900 Stewart Avenue, Suite 301, Garden City, New York, 11530... Now I know what you are saying where the fuck is Garden City! I have lived in NYC my whole life and have no idea.



    WTF-- This is not the NYC I know.... Back to Disney and Key and Peele
     
    #4712     Jan 30, 2022



  3.  
    #4713     Jan 30, 2022
  4. Snap Inc. (SNAP) Has Bottomed.

    I didn't realize SNAP moved so much Friday. I was distracted by snowstorm and family stuff.

    SNAP caught yet another downgrade last week it may of been Thurs it was during the mess and the stk did not go down. Right there I thought about going long. But market conditions and everyone telling me to buy cyclical and cheap stocks kept me away.


    30.42+2.12 (+7.49%)
     
    #4714     Jan 30, 2022
  5. Adobe Van.
    you liked it.

    This other guy likes it. Alan.

    It's probably a buy. The chart is pretty good all things considering.
     
    #4715     Jan 30, 2022
    unconventional wisdom likes this.
  6. VRTX

    Vertex Pharmaceuticals Incorporated
    $243.0214.80 (+6.48%)4:00 PM 01/28/22
     
    #4716     Jan 30, 2022
  7. vanzandt

    vanzandt

    Lol....
    Here, let me try my hand at this...

    GBA's official... "I too can be a savant thread"

    TWLO has Bottomed-$179
    UPST has Bottomed-$95
    TTD has Bottomed-$61
    ADSK has Bottomed-$230
    RBLX has Bottomed-$58


    :rolleyes:
    Damn I'm good.
     
    #4717     Jan 30, 2022
  8. vanzandt

    vanzandt

    And if they don't work out btw...
    ...we just won't mention it.
    That's the secret to becoming ET's best stock-picker for the last 20 years.
    Or so I'm told. :cool:

    upload_2022-1-30_22-24-7.jpeg
     
    Last edited: Jan 30, 2022
    #4718     Jan 30, 2022
  9. vanzandt

    vanzandt

    You're a savant!



    Beyond Meat Stock Leaps On Double Upgrade, Price Target Boost From Barclays

    Barclays analyst Benjamin Theurer boosted his rating and price target on Beyond Meat Monday, noting "more positives than negatives" for the plant-based food group.

    Jan 31, 2022 6:43 AM EST

    Beyond Meat (BYND) - Get Beyond Meat, Inc. Report shares jumped higher Monday after analysts at Barclays issued a 'double upgrade' on the plant-based food group, noting its potential in the U.S. market isn't begin reflected in its stock price.

    Barclays analyst Benjamin Theurer lifted his rating on the stock by two notches, to "overweight", and boosted his price target on the stock by $10, to $80 a share, citing "more positives than negatives" in the U.S. consumer market for alternative meat products.

    "While additional Covid variants could continue delaying a full-blown foodservice recovery, we do expect a gradual recovery will continue," Theurer said. "Moreover, Beyond Meat has been further positioning its products in this channel in the U.S. and in international markets through new partnerships."

    Beyond Meat shares were marked 4.9% higher in pre-market trading to indicate an opening bell price of $59.30 each, a move that would still leave the stock nursing a six-month decline of around 50%.
     
    Last edited: Jan 31, 2022
    #4719     Jan 31, 2022
    unconventional wisdom likes this.
  10. vanzandt

    vanzandt

    Granny's shorts.
    $111.18

    OUTLOOK:
    The outlook for pricing and yields for the remainder of FY22 is hugely uncertain. As announced on 22 Dec., our Jan. capacity was cut by 33% (reducing traffic from approx. 10m to between 6m-7m). While recent bookings have improved, following easing of travel restrictions, the booking curve remains very late and close-in, so Q4 traffic requires significant price stimulation at lower prices to quickly recover load factors which suffered steep declines due to the Omicron collapse in bookings over the Christmas/New Year period. Ryanair's full year traffic forecast remains unchanged at 'just under' 100m passengers, but due to Covid uncertainty the FY22 net loss guidance remains within a wider than normal range of €250m to €450m. This outturn is hugely sensitive to any further positive or negative Covid news flow and so we would caution all shareholders to expect further Covid disruptions before we here in Europe and the rest of the world can finally declare that the Covid crisis is behind us."
     
    #4720     Jan 31, 2022
    Centuria100 likes this.